241 related articles for article (PubMed ID: 27215452)
1. [Efficacy and Security of Intrathecal with Methotrexate in the Treatment of Meningeal Carcinomatosis].
Wu X; Li J; Xiao J; Yang B; Yu L; Wu X; Wan J; Xu H; Kong J
Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):252-6. PubMed ID: 27215452
[TBL] [Abstract][Full Text] [Related]
2. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
3. Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
Fizazi K; Asselain B; Vincent-Salomon A; Jouve M; Dieras V; Palangie T; Beuzeboc P; Dorval T; Pouillart P
Cancer; 1996 Apr; 77(7):1315-23. PubMed ID: 8608509
[TBL] [Abstract][Full Text] [Related]
4. [Intrathecal methotrexate in breast cancer meningeal carcinomatosis - Experience with a new administration schedule].
Cochereau D; Da Costa S; Le Maignan C; Gauthier H; Cochereau J; Espié M; Giacchetti S; Teixeira L
Bull Cancer; 2016 May; 103(5):444-54. PubMed ID: 26987841
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
[TBL] [Abstract][Full Text] [Related]
6. Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
Mrugala MM; Kim B; Sharma A; Johnson N; Graham C; Kurland BF; Gralow J
Clin Breast Cancer; 2019 Oct; 19(5):311-316. PubMed ID: 31175053
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of leptomeningeal carcinomatosis from gastric cancer].
Okuda T; Kataoka K; Kato A
Gan To Kagaku Ryoho; 2009 Apr; 36(4):599-603. PubMed ID: 19381031
[TBL] [Abstract][Full Text] [Related]
8. Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid tumors: a retrospective cohort study.
Scott BJ; van Vugt VA; Rush T; Brown T; Chen CC; Carter BS; Schwab R; Fanta P; Helsten T; Bazhenova L; Parker B; Pingle S; Saria MG; Brown BD; Piccioni DE; Kesari S
J Neurooncol; 2014 Sep; 119(2):361-8. PubMed ID: 24942463
[TBL] [Abstract][Full Text] [Related]
9. Prolonged response of meningeal carcinomatosis from non-small cell lung cancer to salvage intrathecal etoposide subsequent to failure of first-line methotrexate: a case report and literature review.
Park MJ
Am J Case Rep; 2015 Apr; 16():224-7. PubMed ID: 25879815
[TBL] [Abstract][Full Text] [Related]
10. Ventriculolumbar perfusion chemotherapy for the treatment of leptomeningeal carcinomatosis: a phase I study with pharmacokinetic data.
Gwak HS; Lim HS; Shin SH; Yoo H; Han JY; Kim HT; Yun T; Lee JS; Lee SH
Am J Clin Oncol; 2013 Oct; 36(5):491-9. PubMed ID: 22781384
[TBL] [Abstract][Full Text] [Related]
11. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Intrathecal MTX/Ara-C Combined with Systemic Chemotherapy in a Gastric Cancer Patient with Meningeal Carcinomatosis.
Yamasaki T; Fukui H; Sei H; Hara K; Eda H; Kondo T; Toyoshima F; Kono T; Tozawa K; Ikehara H; Tomita T; Oshima T; Watari J; Miwa H
Intern Med; 2016; 55(6):609-11. PubMed ID: 26984076
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of different doses of intrathecal methotrexate in the treatment of leptomeningeal carcinomatosis: a prospective and single-arm study.
Hou L; Han W; Jin J; Chen X; Zou Y; Yan L; He J; Bu H
Jpn J Clin Oncol; 2021 Dec; 51(12):1715-1722. PubMed ID: 34585252
[TBL] [Abstract][Full Text] [Related]
15. Triple intrathecal chemotherapy for leptomeningeal carcinomatosis in solid tumors: Treatment outcomes, response and their determinants.
Srinivasalu VK; Subramaniam N; Philip A; Jose W; Pavithran K
Indian J Cancer; 2021; 58(1):84-90. PubMed ID: 33402572
[TBL] [Abstract][Full Text] [Related]
16. Development of the Metronomic Biofeedback Pump for leptomeningeal carcinomatosis: technical note.
Chen TC; Napolitano GR; Adell F; Schönthal AH; Shachar Y
J Neurosurg; 2015 Aug; 123(2):362-72. PubMed ID: 25955873
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
Jung TY; Chung WK; Oh IJ
Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
[TBL] [Abstract][Full Text] [Related]
18. [A case of meningeal carcinomatosis due to gastric cancer treated with intrathecal chemotherapy].
Kobayashi Y; Sugitani S; Oseki K; Iiri T
Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1696-704. PubMed ID: 21971143
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours.
Beauchesne P
Lancet Oncol; 2010 Sep; 11(9):871-9. PubMed ID: 20598636
[TBL] [Abstract][Full Text] [Related]
20. Meningeal dissemination from an ovarian carcinoma with effective response to intrathecal chemotherapy.
Yamakawa H; Ariga H; Enomoto A; Netsu S; Suzuki Y; Konno R
Int J Clin Oncol; 2009 Oct; 14(5):447-51. PubMed ID: 19856055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]